Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00389-2/fulltext?dgcid=hubspot_email_conferencealerts_uwclh23&utm_campaign=conferencealerts&utm_medium=email&_hsmi=282627646&_hsenc=p2ANqtz-8Vca3-rXqdn6dCZgcMvCAoFP6WGQbbhF-xFktGMSICsrwuWqYFQ1lCe2ICwxjKJKxFCYK1p6fMwSN__r0uq2nTk4XvHQ&utm_content=282627646&utm_source=hs_email